Medicorp Inc.

Medicorp Inc.

Montreal, QC

Company Overview

Nature of Business Medicorp Inc. Is an independent manufacturer and distributor of immunodiagnostic and microbiology test kits.

Major Achievement Developed diagnostic test for tumour markers (PSA, FREE PSA) and hormones (FSH, LH, PRL, GII, TSU, T3, T4 Insulin)

Company History Medicorp Inc. was founded in 1972, as a wholly-owned subsidiary of Medicorp Science Inc.

Company Profile Sales Volume: $5 millions, R&D Expenditures: n/a, Employees: 26, Facilities: 12, 500 sq. ft., Exports: 40% exports with the USA - 15% exports with Europe

  • 45% exports with Asia/Pacific.

Technology Focus Medicorp Inc. markets a full line of RIA (radioimmunoassay kits) and ELISA assays for hormones, therapeutic drugs and vitamins, and a full line of latex agglutination tests for infectious diseases. Both product lines are directed at the clinical laboratory market. Line of genetic engineering reagents to molocular biologists and research reagents to the micro- biologists / immunologist. Solid phase antibody coated tubes for firms on an OEM basis. IRMA, immunoradiometric kits. Monoclonal antibodies.

Company Information

Physical Address

5800 Av. Royalmount
Montreal, QC H4P 1K5
CA

Mailing Address

5800 Av. Royalmount
Montreal, QC H4P 1K5
CA

Phone

Phone: Show phone

Toll Free: Show toll free

Fax: Show fax

Additional Details

Legal Name: Medicorp Inc.

Number of Employees: 26

Total Sales ($CDN): $100,000 - $200,000

Country of Ownership:

CA

Contacts

Pierre Du Ruisseau

Title: Vice President

Area of Responsibility: Management Executive

Phone: Show phone

Fax: Show fax

Products

  • Biotechnology
  • Diagnostic Aids
  • Diagnostic Kits

    Diagnostic kits for the measurement of Pituitary hormones (PSH, LH, TSH, GH, PRL) thyroid hormone (T3U, T4) and placental hormone (HCG). Either by IRMA or ELISA technologies

NAICS Categories

Additional Information

NAICS:

621510

Export Experience:

Germany, Greece, India, Iran, Italy, Spain, United Kingdom, United States

Actively Pursuing:

France, Japan, Mexico